MetaCap

Dyne Therapeutics (DYN) News

NASDAQ: DYNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.50-0.53 (-3.31%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DYN news summary

We found 5 recent headlines mentioning Dyne Therapeutics (DYN): 1 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, DYN is down 3.31% at $15.50. The most recent story, "Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", was published by GlobeNewswire on Nov 19, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Dyne Therapeutics headlines

Compare DYN